New Technology May Improve Visualization Of The Brain During Stroke Treatment - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
New Technology May Improve Visualization Of The Brain During Stroke Treatment Study Announced at Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting


New Technology May Improve Visualization Of The Brain During Stroke Treatment

Study Announced at Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting

PR Newswire

COLORADO SPRINGS, Colo., July 29, 2014 /PRNewswire-USNewswire/ -- New technology in the form of a magnetically-assisted remote-controlled catheter (MARC) which could allow physicians to see and assess brain tissue more clearly while treating a stroke may hold promise, according to study authors who released their findings today at the Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting in Colorado Springs, CO.

The findings stand to advance the field of neurointervention, a specialty that facilitates stroke treatment by navigating a catheter (the tubing through which clot-dissolving drugs or clot retrieval devices are applied) through the blood vessels, from a point of entry in the groin up to the problematic spot in the brain.  Neurointerventionists typically accomplish this approach by manually directing the catheter and visualizing its progress under standard X-ray guidance. 

With MARC, study authors sought to understand if a remote-controlled catheter under Magnetic Resonance Imaging (MRI) guidance could more effectively accomplish maneuvering through complex vessel anatomy, which would ultimately allow improved visualization of the brain tissue affected during a stroke. "Given that MRI is the gold standard by which we determine brain tissue viability, it is exciting that we potentially now have new MRI-compatible technology that enables us, while treating a stroke, to make real-time assessments about whether brain tissue is dead or alive," said Steven Hetts, MD, lead study author and Associate Professor of Radiology at the University of California, San Francisco.  "The implications are numerous, including improved medical decision-making, which would naturally result in  optimizing patient safety and clinical outcomes."

To assess the performance of MARC, Hetts and his colleagues aimed to determine mean procedure times and success data for a custom, clinical-grade MARC prototype under MRI guidance as compared to a manually-navigated catheter, under both MRI and conventional x-ray guidance – each procedure utilizing a cryogel vascular model designed to simulate the main and branch blood vessels in a living human. The MRI-guided procedures were performed at 1.5T (magnetic field strength of a standard clinical MRI scanner) using a balanced steady-state free precession sequence in the type of clinical MRI scanner available in most hospitals. 

Results showed that MARC was clearly visible under MRI guidance and was used to successfully complete 192 (80 percent) of 240 total turns around blood vessels as compared to the manually- directed catheter under both MRI and x-ray guidance, at 144 (60 percent) of 240 total turns and 119 (74 percent) of 160 total turns, respectively.  MARC also was faster than the manually directed catheter under MRI, with a mean procedure time of 37 seconds per turn as compared to 55 seconds, but comparable to the manually directed catheter under x-ray guidance which required a mean of 44 seconds for each turn. When assessing time required to navigate the various angles of branch vessels at turns of 45°, 60°, and 75°, MARC proved to be faster than the manually-directed catheter under MRI guidance.

"Given that the success of neurointerventional stroke treatment is directly tied to how fast and accurately physicians can eliminate the impact of a clot and restore blood flow to viable portions of the brain, technology that facilitates this objective stands to be transformative," said Hetts. "By proving that MRI-guided neurointervention could be more effective than current standard approaches to stroke treatment, we are taking a significant step forward in the advancement of our field."

About SNIS:

Founded in 1992, the Society of NeuroInterventional Surgery (SNIS) is represented by physicians who specialize in minimally invasive techniques to treat neurovascular conditions, including stroke, aneurysms, carotid stenosis and spinal abnormalities.  Drawing on diverse backgrounds and expertise including interventional neuroradiology, neurosurgery and neurology, these physicians are continuing to forge new pathways in the development of the distinct specialty of neurointervention.  Over the past two decades, practitioners of this field have paved the way for the scientific research and study that has resulted in new technology and revolutionary treatment approaches that have transformed the neurosciences.  In keeping with the mission of SNIS, the society remains committed to working in partnership to advance the science and medical environment that will result in enhanced quality of care for patients across the globe.  www.snisonline.org. Follow us on Twitter @SNISinfo.

SOURCE Society of NeuroInterventional Surgery

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document

Click here